Little victories.
Big impact.
Lamzede® (velmanase alfa-tycv) is treatment for adults and children with non-central nervous system symptoms of alpha-mannosidosis.
If you or your loved one has been diagnosed with alpha-mannosidosis, you may have already seen or felt the effects on everyday life. Now there's Lamzede—an enzyme replacement therapy (ERT) for adults and children with alpha-mannosidosis. Because every extra step is in the right direction.
The first and only ERT for alpha-mannosidosis
Until now, there has never been an FDA-approved treatment option designed for alpha-mannosidosis.
The small victories make a big impact
Lamzede is a lifelong therapy that may help slow progression over time.
Don’t delay
Alpha-mannosidosis is a progressive disease, which means it will get worse over time if left untreated.
